Patent · US Active

Screening for structural variants

US11680284B2 · kind B2 · utility

1Cited by
149References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 30, 2018
Grant dateJun 20, 2023
Priority date
Expiry dateJan 26, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q2600/156
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The invention relates to carrier screening and methods for describing a structural variant, such as a large rearrangement or chromosomal abnormality, in a person's genome using probes that are designed to determine the person's genetic sequence and reveal substitution mutations and small structural variants. Identifying a structural variant may include exposing a nucleic acid to a plurality of probes. Each probe has a linked pair of targeting arms designed to hybridize upstream and downstream of a target in a genome. The method includes hybridizing two of the probes to the nucleic acid and attaching the two probes together to create an inter-probe product as well as detecting the inter-probe product and reporting a structural variant of the genome in the nucleic acid.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.